CVR number 32836259
Industry 869600

KIROPRAKTISK KLINIK ENGHAVECENTRET ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.7% 6.6% 6.9% 7.7% 8.3%  
Credit score (0-100)  35 35 34 30 29  
Credit rating  BBB BBB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  4,547 4,641 4,563 5,574 5,503  
EBITDA  2,050 2,318 1,688 2,108 1,889  
EBIT  1,931 2,167 1,537 1,988 1,727  
Pre-tax profit (PTP)  2,011.0 2,156.3 1,527.7 1,987.5 1,726.4  
Net earnings  1,563.7 1,681.7 1,212.6 1,550.1 1,345.6  
Pre-tax profit without non-rec. items  2,011 2,156 1,528 1,988 1,726  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  452 327 226 259 415  
Shareholders equity total  1,818 1,999 1,512 1,862 1,658  
Interest-bearing liabilities  0.0 0.0 0.3 0.0 0.0  
Balance sheet total (assets)  2,460 2,421 1,826 2,319 1,940  
Net Debt  -1,298 -1,397 -1,208 -1,801 -1,218  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,547 4,641 4,563 5,574 5,503  
Gross profit growth  9.9% 2.1% -1.7% 22.2% -1.3%  
Employees  4 5 5 6 8  
Employee growth %  0.0% 25.0% 0.0% 20.0% 33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,460 2,421 1,826 2,319 1,940  
Balance sheet change%  -10.4% -1.6% -24.6% 27.0% -16.3%  
Added value  2,049.6 2,318.1 1,687.9 2,139.0 1,888.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  224 -276 -252 -87 -6  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  42.5% 46.7% 33.7% 35.7% 31.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  78.4% 88.8% 72.4% 96.0% 81.3%  
ROI %  104.9% 110.9% 87.5% 117.9% 98.4%  
ROE %  82.9% 88.1% 69.1% 91.9% 76.5%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  73.9% 82.6% 82.8% 80.3% 85.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -63.3% -60.3% -71.5% -85.5% -64.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 5,886.6% 746.9% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  3.5 4.8 4.8 4.3 5.1  
Current Ratio  3.5 4.8 4.9 4.3 5.1  
Cash and cash equivalent  1,298.3 1,396.8 1,208.0 1,801.2 1,218.1  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,390.6 1,607.5 1,212.4 1,529.8 1,169.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  512 464 338 357 236  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  512 464 338 351 236  
EBIT / employee  483 433 307 331 216  
Net earnings / employee  391 336 243 258 168